Valuation Ipsen Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 13:09:03 11/08/2026 +03			5-day change	1st Jan Change
157.35 ^EUR	-2.39%		+0.51%	+32.60%

08-04	Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration	CI
08-03	Jefferies Downgrades Ipsen to Underperform, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,979	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	32.85%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,746	10,738	9,943
Change	-	16.81%	12.22%	1.81%	2.28%	27.33%	-8.59%	-7.41%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13.2x	13.9x	13.9x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.54x	2.16x	1.86x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-2.62x	-261.68x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.85x	2.84x	2.74x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.58x	2.35x	2.1x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.22x	6.23x	5.82x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.36x	7.25x	6.68x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	9.11x	9.26x	8.59x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	11%	10.8%	11.6%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.97%	0.97%	1.05%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.03	11.39	11.38
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	13.5%	14.5%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,553	4,571	4,743
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,888	1,723	1,709
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,596	1,481	1,487
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,002	960.3	951.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,233	-2,241	-3,036
Reference price ²	80.50	100.50	107.90	110.70	119.00	158.30	158.30	158.30
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	2/11/22 A	2/9/23 A	2/8/24 A	2/13/25 A	2/12/26 A	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.93x	12.78x	25.81x	0.56%	1,098B
JOHNSON & JOHNSON	29.12x	-	-	2.05%	631B
ABBVIE INC.	31.66x	7.38x	15.33x	2.77%	438B
ROCHE HOLDING AG	20.79x	4.93x	12.21x	2.68%	368B
NOVARTIS AG	22.24x	5.75x	14.34x	2.79%	298B
ASTRAZENECA PLC	20.77x	4.28x	12.16x	2.05%	251B
AMGEN INC.	26.18x	6.87x	12.22x	2.42%	226B
NOVO NORDISK A/S	13.88x	4.98x	10.54x	3.66%	209B
GILEAD SCIENCES, INC.	-41.32x	5.92x	33.42x	2.48%	165B
Average	17.58x	6.61x	17.00x	2.38%	409.37B
Weighted average by Cap.	25.00x	8.33x	18.79x	1.95%